日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

New treatment approved for marginal zone lymphoma

chinadaily.com.cn | Updated: 2023-05-24 17:50
Share
Share - WeChat

Chinese biopharmaceutical company, InnoCare Pharma, announced that its new BTK inhibitor, "Orelabrutinib", has received approval from the National Medical Products Administration (NMPA) for the treatment of relapsed/refractory marginal zone lymphoma (MZL), making it China's first and only approved BTK inhibitor for this indication. MZL is a type of indolent B-cell non-Hodgkin lymphoma, the second most common lymphoma in China, with about 8.3% of all lymphomas and 15% of B-cell lymphomas. The disease mainly affects middle-aged and elderly people and has been on the rise globally.

In China, there is a lack of effective treatment options for patients with MZL who experience disease progression or relapse after first-line treatment. According to Ma Jun, director of the Harbin Institute of Hematology and Oncology and supervisor of the board of directors of the Chinese Society of Clinical Oncology (CSCO), the five-year disease-free survival rate of lymphoma in China is only around 37%-40%, significantly lower than that in Europe and the United States, where the five-year disease-free survival rate of overall lymphoma has reached 70%.

Ma believes that the treatment dilemma facing MZL patients is due to the complexity of the disease. The primary site of MZL is highly diverse, with complex extranodal presentations and high heterogeneity, posing a significant challenge for treatment. Additionally, current drugs cannot meet clinical needs, and although immunotherapeutic drugs are available for the treatment of relapsed/refractory MZL, they need to be combined with chemotherapy drugs. Since elderly patients make up the majority of those with MZL, they are more prone to intolerance and suboptimal therapeutic effects, resulting in the needs for better treatment in this indication.

BTK is a tyrosine kinase encoded by the human BTK gene, which plays a crucial role in the B-cell receptor signaling pathway, leading to B-cell proliferation, survival, differentiation, and cytokine production. BTK inhibitors can bind to BTK and inhibit its self-phosphorylation, blocking signal transduction and inducing cell apoptosis, thus inhibiting the development of B-cell tumors. In recent years, BTK has attracted widespread attention as a key target for the treatment of MZL.

According to Ma Jun, the approval of Orelabrutinib for the treatment of relapsed/refractory MZL provides better weapons for the treatment of the disease, potentially prolonging patients' disease-free survival. However, he reminds patients that any medication has side effects. Once any side effects occur, such as bleeding, platelet decrease, leukocyte decrease, infection, or changes in cardiac function, patients should keep in touch with their doctors and receive prompt treatment.

He also emphasizes the importance of coordination among doctors, pharmaceutical companies, and healthcare policymakers, to ensure better treatment outcomes for patients.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 亚洲一区二区三区四区在线观看 | 福利视频中文在线观看 | 日韩乱轮| 久久丁香 | 色哟哟国产成人精品 | 欧美国产日韩一区二区三区 | 婷婷国产成人久久精品激情 | 波多野结衣一区二区三区四区 | 午夜影院在线观看视频 | 最新中文字幕日本 | 国产精品99一区二区三区 | 一区二区免费 | 91麻豆精品国产91久久久更新时间 | 日本中文字幕一区 | 老色鬼久久AV综合亚洲健身 | www一区二区三区 | 成人在线视频黄色 | 欧美国产日韩一区二区三区 | 99热国产精品 | 久久久久毛片免费观看 | 碰碰碰精品视频在线观看 | 我不卡在线 | 波多野结衣在线高清视频 | 欧美日韩亚洲一区 | 99视频有精品视频免费观看 | 午夜九九九 | 韩国美女丝袜一区二区 | 亚洲电影免费观看高清完整版在线观 | 嫩草视频在线播放 | 亚洲 欧洲 偷拍 校园 另类 | 97av视频在线播放 | 免费福利视频在线观看 | 日本免费不卡在线一区二区三区 | 精品国产乱码久久久久久1区2区 | 中国免费毛片 | 91 在线观看 | 欧美福利一区二区三区 | 99re热这里只有精品视频 | 九色九色久综色鬼在线 | 久久精品男人 | 成人深夜福利 |